Myriad Genetics announced that James Evans will retire as its CFO "in order to attend to family health issues." Evans will continue to perform his duties until a replacement is found. Myriad said it will hire an executive search firm to identify candidates for consideration.
Evans joined Myriad in 1995 as corporate controller and was promoted to VP of finance in July 2005. He became CFO in November 2007. Evans played a leading role in Myriad's recent acquisitions of Rules-Based Medicine and Crescendo Biosciences.
St. Jude Children's Research Hospital has appointed three internationally renowned physician-scientists to leadership positions -- Mitchell Weiss, J. Paul Taylor, and Kim Nichols.
Weiss, professor of pediatrics at the University of Pennsylvania, will chair St. Jude's hematology department.
Taylor, who joined the hospital in 2008, will now chair St. Jude's new department of cell and molecular biology, and hold the Edward F. Barry Endowed chair in cell and molecular biology.
Nichols, director of the CHOP Pediatric Hereditary Cancer Predisposition Program, will launch St. Jude's new division of hereditary cancer predisposition within the oncology department.